Theseus PharmaceuticalsTHRX
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Theseus Pharmaceuticals Inc. (THRX) in their 13F filings. The largest holder was Goldman Sachs Group Inc. ($0).
- Company
- Theseus Pharmaceuticals Inc.
- CUSIP
- 88369M101
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 70 | $145.7M |
Ownership 1 holders
| Goldman Sachs Group Inc. | 0.00% | Add +78.8% | 30,366 | $0 |
"% of holder's portfolio" is THRX's weight in each manager's 13F, not the share of Theseus Pharmaceuticals Inc. the manager owns.